Cargando…
Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
BACKGROUND: SARS-CoV-2 infection demonstrates a wide range of severity. More severe cases demonstrate a cytokine storm with elevated serum interleukin-6, hence IL-6 receptor antibody tocilizumab was tried for the management of severe cases. AIMS: Effect of tocilizumab on ventilator-free days among c...
Autores principales: | Mady, Ahmed F., Abdulrahman, Basheer, Mumtaz, Shahzad A., Al-Odat, Mohammed A., Kuhail, Ahmed, Altoraifi, Rehab, Alshae, Rayan, Alharthy, Abdulrahman M., Karakitsos, Dimitrios, Aletreby, Waleed Th. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949015/ https://www.ncbi.nlm.nih.gov/pubmed/36844963 http://dx.doi.org/10.2478/rjaic-2022-0001 |
Ejemplares similares
-
“Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis
por: Mady, Ahmed F., et al.
Publicado: (2022) -
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
por: Mady, Ahmed, et al.
Publicado: (2020) -
Fulminant septic shock due to Edwardsiella tarda infection associated with multiple liver abscesses: a case report and review of the literature
por: Bakirova, Gultakin Hasan, et al.
Publicado: (2020) -
From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
por: Rana, Muhammad Asim, et al.
Publicado: (2015) -
Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study
por: Mhawish, Huda, et al.
Publicado: (2021)